Pharmaceutical industry undergoes various operations including pharmaceutical plant design, engineering, and construction. According to the market research report “Chemical and Pharmaceutical Plants (Construction) in Malaysia: Market Analytics by Category & Cost Type to 2021“, for a successful international pharmaceutical plant construction, at first, the objective is aligned for all participant involved in the plant construction of chemical and pharmaceutical. The project manager must be seasoned veteran with pharmaceutical facility delivery. There are number of pitfalls faced by project manager like off shore contractual issue, commercial issues, relationship building, site-specific risks, etc. in remote location of construction procurement and shipping concern should be well managed. Before the reach of ultimate purpose a great deal of effect is required which must be completed and managed properly?
The leading provider services of the pharmaceutical industry in Malaysia are Fluor. It provides engineering, procurement, construction and validation (EPCV) services. It is designed to build various types of bulk pharmaceutical facilities, continuous and semi-continuous operations and it helps in employing batch. The operations include pilot plant facilities, full multipurpose commercial scale facilities, high containment facilities, Bulk Active Pharmaceutical Ingredients and some solids and liquids.
There are number of equipment used I manufacturing chemical and pharmaceutical plant. The material used should have strength, mass, wear properties, thermal conductivity, thermal expansion, transparency, economical, ease of fabrication, smooth and polished surface, sterilization mechanism.
In Bio-Xcell Biotechnology Park in Nusajaya, Johor, Malaysia, there was construction of multiproduct biologics facility by Stelis Biopharma of US$60m. With mammalian and microbial suites,the plant was designed which incorporated the latest single-use bioreactor systems with the objective of manufacturing drug substances and addition to high-speed filling lines with isolators for sterile finished products in every format. There was a R&D unit, which was conductedto scale-up, the process development studies.
To amplify the reach with bighearted tax laws, incentives and its location considered prime for servicing Southeast Asia, Malaysia continues to draw new plants from manufacturers. Strides alsohad entered into an agreement with Cipla and Medicines for Malaria Venture to develop a rectal artesunate for treating children with severe malaria.
For further details of the report visit:
Ankur Gupta, Head Marketing & Communications